Four sulfur mustard exposure cases: Overall analysis of four types of biomarkers in clinical samples provides positive implication for early diagnosis and treatment monitoring  by Xu, Hua et al.
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In one  event,  Chinese  male  individuals  accidentally  exposed  to unknown  chemicals  and
emerged  erythema  or blisters  on contacted  organism  derma,  then  hospitalized.  To  identify
the causative  agents,  blood,  urine  and  exudate  samples  were  collected  from  the  patients
during  the therapeutic  course.  Five  established  liquid  chromatography–mass  spectrome-
try  (LC–MS)  and  gas  chromatography  (GC)–MS methods  were  employed  to analyze  the
samples.  Here,  an  overall  analysis  of four  types  of sulfur  mustard  biomarkers,  includ-
ing  the hydrolysis/oxidation  products,  -lyase  metabolites,  DNA  adducts  and  hemoglobin
adducts,  was  conducted  toward  the  samples  from  exposed  individuals.  The  results  of all
the four  types  of  biomarkers  in  different  biomedical  matrices  showed  high  relevance,
and  veriﬁed  that this  exposure  is indeed  originated  from  sulfur  mustard.  The  concentra-
tions  of  the  biomarkers  in specimens  revealed  a good  correlation  with  the  severity  of  the
patient’s  symptom.  The  concentration-time  proﬁle  demonstrated  that  most  of  the  biomark-
ers quickly  achieved  maximum  at the  beginning  of the  course,  and  then  decreased  and  kept
a detectable  level  until  the  7th  day  after  exposure.  The  DNA  adducts  in urine  samples  still
appeared  on the  30th  day,  and  the  N-terminal  valine  adducts  in  hemoglobin  could  be mon-
itored  for over  90  days,  which  was  meaningful  for the concurrent  study  of  clinical  samples.
To the  best  of  our  knowledge,  this  work  provides  the  total  analysis  and  proﬁle  of  fourlood
xudate
categories  of biomarkers  in  human  specimens  for the ﬁrst  time,  and the good  accordance
between  concentration  and  level  of burns, between  time  course  and  biomarkers  will  be of
great  importance  for early  diagnosis  and  medical  treatment  monitoring  of  sulfur  mustard
exposure.
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1. IntroductionSulfur mustard (SM, U.S. Code HD, chemical name
2,2′-dichloroethyl sulﬁde) is a powerful vesicant and a
biological alkylating agent, which can function via inhala-
tional,  cutaneous and ocular routes of exposure [1,2]. It has
 access article under the CC BY-NC-ND license (http://creativecommons.
gy Repor534 H. Xu et al. / Toxicolo
been employed as a chemical warfare agent since World
War  I, and has a continued strike in more recent Middle
Eastern conﬂicts [3]. SM was also a predominant agent
found in the chemical weapons abandoned in China by the
Japanese  imperialist army after World War  II. The old shells
or  containers of SM are still a large threat to civilian health.
To  date, accidental human injuries by SM occurred from a
variety  of situations have been reported [4–8]. Because of
its  ease of preparation, SM also poses a potential threat to
public  safety if abused by terrorists.
As a bifunctional alkylating agent, SM reacts rapidly
with numerous nucleophiles, i.e., water, glutathione, DNA
and  proteins under physiological conditions via the inter-
mediate  episulfonium ion (Fig. 1). The corresponding
four major metabolic routes have been identiﬁed in
animal models (e.g., rat and mouse) [9–13]. The ﬁrst
pathway involves the direct oxidation product of SM,  bis-
-chloroethyl sulfoxide (SMO), the directly hydrolyzed
metabolite thiodiglycol (TDG), and its oxidation prod-
uct  thiodiglycol sulfoxide (TDGO). The second pathway
involves a reaction with abundant glutathione and then
undergoing oxidation to the sulfone followed by -lyase
cleavage, leading to the formation of 1,1′-sulfonylbis[2-S-
(N-acetylcysteinyl) ethane] (SBSNAE), 1,1′-sulfonylbis[2-
(methylthio) ethane] (SBMTE), 1-methylsulﬁnyl-2-[2-
(methylthio)ethylsulfonyl]ethane (MSMTESE) and 1,1′-
sulfonylbis  [2-(methylsulﬁnyl) ethane] (SBMSE). The third
way  is the reaction on the critical nucleophilic sites in
DNA  to produce SM-DNA adducts. The major sites of
DNA  alkylation by SM include N7, O6 positions of gua-
nine, N3 position of adenine, and interstrand or intrastrand
crosslinks at the N7 position of guanine, and adducts of
N7-[2-[(2-hydroxyethyl)thio]ethyl]-guanine (N7-HETEG),
O6-[2-[(2-hydroxyethyl)thio]ethyl]-guanine (O6-HETEG),
N3-[2-[(2-hydroxyethyl)thio]ethyl]-adenine (N3-HETEA),
and  bis[2-(guanin-7-yl)ethyl] sulﬁde (Bis-G) are corre-
spondingly formed. The last pathway involves the reaction
with  various amino acid residues present in proteins,
among which the HETE-valine (HETE-Val) adduct of
hemoglobin and HETE-cysteine adduct of albumin are of
the  most attention now.
The biological fate of SM has been fully investigated
in rats, while a complete understanding of SM in humans
is  lacking. This is due that, biological samples of alleged
victims available for analysis are rare or difﬁcult to be
achieved, and new trace analytical methods to detect SM
attached  to long-lived proteins, DNAs, and other biomark-
ers  are only vast improved in the last decade by virtue of
booming chromatography–mass spectrometry technique.
Basically, now researchers have the feasible tools to access
the  archived or freshly collected specimens, typical blood
or  urine samples, and ﬁnd evidence after SM attack or acci-
dent.
For  two subjects between 2 and 3 days after an acci-
dentally cutaneous exposure to SM,  free metabolites have
been  studied in the urine samples, the glutathione derived
-lyase  metabolites SBMSE, MSMTESE, and hydrolysis
products TDG, TDGO were identiﬁed in both individuals
[14]. The -lyase metabolites of SM in the urine of casu-
alties are proposed as unequivocally diagnostic indicators
of  SM poisoning in human [15]. With regard to archivedts 1 (2014) 533–543
blood samples of four hospitalized Iranian casualties 5–10
days  after exposure and one individual 2 days after an acci-
dental  exposure to SM,  SM-alkylated hemoglobin adducts
including HETE-histidine and HETE-Val adducts have been
found  for SM exposure [16]. In another case, archived blood
samples  of two hospitalized Iranians 22 and 26 days post
a  suspected SM exposure were tested positive for both the
HETE-Val  adduct and N7-HETEG [17]. For nine Iranian indi-
viduals  exposed to SM,  the archived blood specimens were
tested  positive for SM-alkylated albumin [18] and HETE-Val
adduct of SM-hemoglobin [19]. In a most recent report, for
two  individuals 2–42 days after exposure, positive results
of  biomedical samples were obtained for SM poisoning.
Notably, only in this case, two different biological matri-
ces  from an individual were used to mutually verify the SM
exposure,  in which the free metabolites of SM in urine and
SM-albumin adduct in blood were tested positive [15,20].
All  above-mentioned reports indicated some similar-
ity in metabolism of SM in human and rat. Generally,
hydrolyzed/oxidation metabolites and -lyase cleavage
products formed in relatively high concentrations in early
samples  and persist only for several days due to the rela-
tively  rapid elimination, while DNA- and protein adducts
existed for a relatively long time and thus offer valu-
able evidence for veriﬁcation of SM exposure even weeks
to  months later. However, these researches only investi-
gated one or up to two types of biomarkers in the clinic
specimens, which cannot directly and comprehensively
demonstrate the biological fate of SM in humans.
To address this issue, this paper provides a total analysis
of  four types of SM biomarkers in three different biomed-
ical  matrices collected from individuals who  exposed to a
vesicating  agent in one accident. To identify the causative
agent, blood, urine and blister exudate ﬂuid samples col-
lected  from four representative cases with different extent
of  exposure symptoms were detected. A series of liq-
uid  chromatography–mass spectrometry (LC–MS) and gas
chromatography (GC)–MS methods previously established
and validated in our laboratory [13,21–27] were employed
to  measure and proﬁle the hydrolysis/oxidation products,
-lyase metabolites, DNA adducts and hemoglobin adducts
in  the samples. The correlation between concentration
of biomarkers and level of burns were investigated. The
detection windows of the four types of biomarkers were
suggested, and thus a choice of suitable biomarker in cer-
tain  biomedical samples were promoted. To the best of our
knowledge, this is the ﬁrst and detailed paper of four kinds
of  SM biomarkers in a typical exposure event in worldwide,
it  will be of great importance for early clinical diagnosis and
medical  treatment monitoring of SM exposure.
2. Materials and methods
2.1.  CautionSM is a highly reactive alkylation vesicant and cytotoxic
agent. Handling of this agent should be carried out in the
well-ventilated fume hood. The use of gloves and stringent
protective measures must be adopted.
H. Xu et al. / Toxicology Reports 1 (2014) 533–543 535
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aig. 1. The four major metabolic routes of sulfur mustard. The main metab
ere  presented, including hydrolysis and oxidation products, -lyase pro
.2. Chemicals and materials
SM  (96% purity) was  provided by the Institute of
hemical Defense of Chinese People’s Liberation Army.
euterated TDG (TDG-d8) and dibenzothiophene were
urchased from the Cambridge Isotope Laboratories
Tewksbury, MA,  USA). Heptaﬂuorobutyryl imidazole
HFBI) was obtained from TCI (Tokyo, Japan). Ana-
ytical standards and isotopically labeled standards
or TDGO, SMO, SBSNAE, SBMTE, MSMTESE, SBMSE,
,1′-Sulfonylbis[2-(ethylsulﬁnyl) ethane] (SBESE), 1,1′-
ulfonylbis[2-(ethylthio)ethane] (SBETE), N7-HETEG, Bis-
,  N3-HETEA and O6-HETEG were synthesized in our
aboratory, and the purities of these reference substances
ere greater than 95%, their deuterated ratios were
ver 99%, which were determined by nuclear magnetic
esonance, LC–MS or GC–MS. Toluene, dichloromethane,
thyl acetate, methanol and acetonitrile were of HPLC
rade and obtained from J.T. Baker (Phillipsburg, NJ,
SA).  TDG, 5-ﬂuorobenzoyl chloride (PFBZ), pentaﬂuo-
ophenyl isothiocyanate (PFPITC), -glucuronidase and
ll  other chemicals, unless otherwise noted, were from
igma-Aldrich (Louis, MO,  USA). TiCl3 (20% solution in
 M hydrochloric acid) was purchased from Acros (Mor-
is  Plains, NJ, USA). Ultrapure water was generated by a
illi-Q  A10 water puriﬁcation system (Bedford, MA,  USA).
lorisil  with 60–100 meshes were from Alltech (Deerﬁeld,
L,  USA). The HLB columns were purchased from Waters
Milford, MA,  USA).
.3.  Clinical patient samples
The  four male individuals mentioned in this report acci-
entally contacted with an unknown viscous oily liquid
ontained in barrel at a construction site. After a latency
eriod of 3–18 h, skin erythema, tingling sensation and blis-
ering  appeared in these individuals. Approximately 24 h
fter  the chemical contact, patients were transferred to aucts studied in this paper corresponding to the four metabolite pathways
NA adducts and protein adducts.
burn  center due to the aggravated symptoms. The signs
and  symptoms of these individuals were classiﬁed when
hospitalized (Table 1). All patients received symptomatic
treatment including local antibiotics, anti-inﬂammatory,
hepatoprotection, kidney protection, myocardial and nerve
nutrition,  and microcirculation improvement. For patients
2–4,  a wound debridement was performed to remove the
affected  areas and the big blisters on them were treated
with vacuum sealing drainage. The eye injury of patient 3
was  treated with soothing eye solution several times a day.
After  4–6 weeks, satisﬁed wound healing was observed
in these patients although with regular pigmentation and
some  scars and keloids.
With  regard to the collection and analysis of clinical
specimens, all four patients have signed the informed con-
sent  forms. Blood samples were collected from the four
patients daily on days 3–32 after the exposure, and then
weekly samples were taken up to 95 days after the expo-
sure  except 60 days for patient 1. The mid-morning urine
samples were collected at the same time points. Blister exu-
date  samples were collected from patients 2, 3, and 4 on
days  3–6 after the exposure, but exudates with very small
volume were collected from the blisters beyond day 6 due
to  the positive treatment effect. All samples were aliquot
and  stored at −70 ◦C on receipt.
2.4.  GC–MS analysis of TDG or/and TDGO in urine
samples
A highly-sensitive isotope dilution (ID)–negative chem-
ical  ionization (NCI)–GC–MS method was established on an
Agilent  6890N GC-5975 MSD  (Agilent, Palo Alto, CA, USA)
in  our laboratory [25]. The sample preparation procedures
included solid-phase extraction (SPE) and derivatization.
Brieﬂy, when measuring sole TDG in the urine, each urine
sample of 100 L was  spiked with 6 ng TDG-d8. Florisil
silica SPE cartridges (500 mg/3 mL)  were pre-conditioned
with 4 mL ethyl acetate, and then samples were applied
536 H. Xu et al. / Toxicology Reports 1 (2014) 533–543
Table 1
The  clinical diagnostic results of the four patients.
Subject Latency period Injured regions Degree of chemical burn
I◦ (%) II◦ (%)
1 18 h Right wrist 1 –
ft wrist
, left leg
t knee, r2  7 h Hands, left forearm, le
3  3 h Right foot, right ankle
4  13 h Hands, left wrist, righ
to the cartridges and eluted with 3.5 mL  ethyl acetate and
centrifuged to dryness at 50 ◦C. Aliquots of 80 L pyri-
dine, 50 L ethyl acetate, and 20 L PFBZ were added and
allowed to react at 50 ◦C for 10 min. Next, 150 L toluene
was added and the solution was vortex mixed for 5 min.
0.1  mol/L of sodium acetate buffer (pH 5.0) was added for
washing,  the derivatized products were then reloaded to a
new  Florisil silica SPE column pre-equilibrated with 4 mL
ethyl  acetate and 4 mL  CH2Cl2, consequently. Washing by
2  mL  CH2Cl2 and 0.4 mL  ethyl acetate, the product was
eluted by 1.5 mL  ethyl acetate. The obtained products were
centrifuged to dryness at 50 ◦C, reconstituted in 50 L of
toluene, and analyzed via ID–NCI–GC–MS.
The GC equipment was mounted with a HP-5MS cap-
illary column (25 m × 200 m × 0.33 m).  The GC oven
temperature was set at 100 ◦C and held for 1 min, increased
to  290 ◦C by a linear ramp at 25 ◦C/min, and held for 5 min.
The  ﬂow of helium carrier gas was set at 0.8 mL/min and
injections were made in splitless mode for 30 s. The injec-
tion  volume was 1 L, with the injector and transfer line
were  both kept at a temperature of 280 ◦C, and methane
was the reactant gas. The ion source and quadrupole tem-
peratures were both 150 ◦C. Selective ion monitoring (SIM)
mode  was used for monitoring m/z 510 (target ion) and 518
(deuterated internal standard) of TDG and TDG-d8, respec-
tively.  In each analytical run, clinical samples, blank urine,
quality  control (QC) samples and a complete calibration
standard set were all included.
For  analysis of combined TDG and TDGO, ﬁrstly, a reduc-
tion  step was conducted with 1 mL  TiCl3 to the urine
sample, and incubation at 75 ◦C for 1 h. Other pretreatment
and analysis procedures were the same as the analysis of
TDG.
2.5.  GC–MS/MS analysis of the ˇ-lyase metabolites in
urine  samples
In  the analysis, the urine samples were ﬁrst treated
with TiCl3 to reduce the mono and di-sulfoxides (SBMSE,
MSMTESE) to the disulﬁde (SBMTE) so that the three pos-
sible  metabolites were traced from a single analyte [22].
Aliquots of 0.5 mL  clinical urine specimens, blanks, QCs
and  standards were pipetted into 15 mL  screw-cap culture
tubes.  The samples were added 50 L of 1 g/mL SBETE
solution to give an internal standard concentration of
100  ng/mL. Aliquots of 0.5 mL  TiCl3/20% HCl solution were
added  to the samples and mixed. The mixtures were then
incubated for 1 h at 75 ◦C. After cooling to room tempera-
ture, 680 L of 5 mol/L NaOH were added and vortex-mixed
immediately until the precipitate turned white completely.
Aliquots of 2 mL  water were added, and the mixtures and perineal region 15 3
, right wrist and face 7 2
oot of right thigh and left toes 8 2
were well mixed and centrifuged at 5000 rpm for 20 min.
The  supernatants were transferred into the 3 mL  HLB car-
tridges.  The cartridges were pre-washed with 5% ammonia
water, water, 2% formic acid and 10% acetonitrile in order,
and  the elutes containing SBMTE were collected by 3 mL
acetonitrile. The solution of 2 L was subjected to the
GC–tandem MS  (MS/MS) analysis.
The GC–MS/MS analysis was performed on a TSQ
Quantum GC–triple-quadrupole MS/MS  with an elec-
troionzation source (Thermo-Fisher Scientiﬁc, San Jose, CA,
USA).  The GC column was a DB-17MS capillary column
(30 m × 250 m × 0.25 m).  The helium carrier gas ﬂow
was  set at 1 mL/min. Sample injection time was  0.5 min  in
a  splitless mode. The injection temperature was 250 ◦C and
the  transfer-line temperature was 260 ◦C. The source tem-
perature was set at 250 ◦C. The initial GC oven temperature
was  90 ◦C and held for 2 min, followed by a linear ramp at
20 ◦C/min to 290 ◦C, which was  held for 4 min. Multiple-
reaction monitoring (MRM)  mode in MS  was used, with
m/z  140 → m/z 75 transition for SBMTE and m/z 154 → m/z
89  transition for internal standard SBETE.
2.6. LC–MS/MS analysis of the hydrolysis/oxidation
products and ˇ-lyase metabolites in urine, blood and
blister exudates
A  sensitive and rapid quantiﬁcation method with ultra-
high  performance LC (UPLC)–MS/MS has been developed in
our  laboratory for simultaneous determination of seven SM
biomarkers  in samples including the oxidative/hydrolysis
products (TDG, TDGO and SMO) and glutathione-derived
metabolites (SBSNAE, SBMTE, MSMTESE and SBMSE) [21].
The  method was  fully validated to meet the bioanalyt-
ical requirements and was employed in this report to
detection the metabolites in the specimens of blood, urine
and  blister exudate. Aliquots of 100 L blood samples,
100 L exudate sample or 1 mL  urine samples were precip-
itated with acetonitrile–methanol (4:1, v/v), and analyzed
by  UPLC–MS/MS with a Waters ACQUITY UPLC system
(Waters, Manchester, UK) and Qtrap 5500 tandem mass
spectrometer (AB Sciex, Foster City, MA,  USA). Clinic sam-
ples,  blanks, QCs and standards were analyzed.
2.7. LC–MS/MS analysis of SM-DNA adducts in urine and
blood  samples
A  simultaneous quantiﬁcation method of N7-HETEG,
O6-HETEG, N3-HETEA and Bis-G in the urine or blood sam-
ples  exposed to SM was  developed and validated with an
ID–UPLC–MS/MS in a positive MRM  mode (Waters UPLC-
AB  Sciex Qtrap 5500 tandem MS). The systematic validation
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f the method and its use in urine samples has been recently
etailed discussed [27]. The brief procedures for the detec-
ion  of four SM-DNA adducts in blood specimens were as
ollowing.
The  human blood samples were processed to isolate
NA as the same procedures described previously [13].
he  obtained DNA was digested by a formic acid hydrol-
sis  at pH 3.5 with incubation at 90 ◦C for 1 h. After cooling
own to room temperature, the mixture was centrifuged
t 12,000 rpm for 15 min, supernatant of 0.3 mL  was evapo-
ated  to dryness and redissolved in 70 L water containing
xed concentration of deuterated ISs at 117 ng/mL for
PLC–MS/MS analysis.
In  UPLC–MS/MS analysis, the HPLC column was a
aters ACQUITY UPLC BEH C18 (50 mm × 2.1 mm i.d.,
.7  m)  operated at 0.35 mL/min. Mobile phase A was
eionized water and phase B was HPLC-grade methanol.
he gradient proﬁle started with 15% B and held 1 min, then
inearly  increased to 60% B over 1 min  and held for 0.5 min,
hen  B% decreased to 15% in 0.1 min  and held for 1.4 min,
he  total run time was 4 min. An injection of 3 L sample
xtract was used for all analyses. The quantiﬁcation precur-
or/product ion pairs monitored for N7-HETEG, O6-HETEG,
3-HETEA and Bis-G were m/z 256 → 105, m/z 256 → 105,
/z  240 → 105 and m/z 389 → 210, and for corresponding
euterated ISs were m/z 260 → 109, m/z 260 → 109, m/z
44  → 109 and m/z 393 → 214, respectively.
.8. GC–MS analysis of HETE-valine adduct of
emoglobin in blood samples
The  exposed blood samples for N-terminal valine
dducts in hemoglobin was analyzed by the method devel-
ped  in our laboratory [23,24]. Brieﬂy, the globin was
rstly  isolated according to the procedure described by
ailey  et al. [28]. The obtained globin was dissolved in
ormamide (10 mg/mL) and incubated with 8 L pyridine
nd 8 L PFPITC along with 50 L deuterated IS solu-
ion of 10 mg/mL  at 60 ◦C for 2 h. After cooling to room
emperature, the mixture was extracted for three times
sing  toluene (of 1 mL  each) and the organic layers were
erged and washed with water (of 0.5 mL  each, for 2
imes),  0.1 mol/L Na2CO3 solution (of 0.5 mL), and water
of  0.5 mL). The toluene layer was dried with anhydrous
gSO4, then evaporated to dryness under nitrogen, and
issolved in 100 L toluene. The samples were applied
nto a Florisil cartridge (500 mg,  3 mL)  which precondi-
ion with 4 mL  ethyl acetate/dichloromethane at 1:9 (v/v)
atio  followed by 2 mL  dichloromethane. The cartridges
ere washed with 2 mL  dichloromethane and 1 mL  ethyl
cetate/dichloromethane at 1:9 (v/v) ratio and the analytes
ere  then eluted with 2 mL  ethylacetate/dichloromethane
t 1:9 (v/v) and evaporated to dryness. The elute was dis-
olved  in 200 L toluene and derivated with HFBI of 14 mg
t  60 ◦C for 30 min. The reaction mixture was washed with
00  L water, 200 L of 0.1 mol/L Na2CO3 and again with
ater before vaporization to dryness. It was redissolved in
0  L toluene and analyzed by ID–NCI–GC–MS.
GC–MS analysis was performed on a 6890N GC-5975
S  detector, together with a 7683B autoinjector (Aglient,
alo  Alto, CA, USA). The GC column was a HP-5MS capillaryts 1 (2014) 533–543 537
column (25 m × 200 m × 0.33 m).  Helium was used as
the carrier gas in the constant ﬂow of 0.8 mL/min. The oven
temperature was initially held at 120 ◦C for 2 min, increased
to  280 ◦C at a rate of 20 ◦C/min, and ﬁnally held at 280 ◦C
for  5 min. Splitless injections of 1 L were made with an
autosampler for 30 s. The injector and transfer-line temper-
atures  were 260 ◦C and 280 ◦C, respectively. An MS  analysis
was  conducted using NCI with methane as the reactant
gas. The source and quadrupole temperatures were both
set  at 150 ◦C. Anions at m/z 564 (M−-3 HF, analyte) and
568(M−-3HF, IS) were monitored in SIM mode.
3.  Results and discussion
According  to the symptoms and contact histories of the
patients, it is largely suspected that they have intimately
contacted with one barrel containing WWII  abandoned
chemical weapons in China, and the most responsible
causative agent might be SM.  Urine, blood and blister
exudate samples collected from four patients who  had
developed various degrees of blistering were tested for
SM  related breakdown products or adducts, i.e., hydroly-
sis/oxidation products, -lyase metabolites, DNA adducts
and  protein adducts, with an aim to provide full evidence
from mutual corroboration.
3.1.  Hydrolysis/oxidation products in urine, blood and
exudate samples
It  should be noted both TDG and TDGO are endoge-
nous substances, their background values in vivo were
0–1  ng/mL and 2–8 ng/mL, respectively [29,30]. Only data
with  statistical difference can be considered for the
inﬂuence of administrated exogenous matter. The hydrol-
ysis/oxidation products of SM were initially analyzed in
urine  samples by the established ID–NCI–GC–MS method.
As  shown in Table 2, TDG or TDG plus TDGO in the urine
samples from four patients collected from day 3 to 7 can
be  positively detected, and all values are greater than the
limits  of detection (LLOD) of 0.1 ng/mL for both metabo-
lites, but only part of data are larger than the background
values. TDG plus TDGO were found in much higher con-
centration than TDG, meaning that the concentration of
TDGO  in exposed humans was higher than that of TDG, as
previously reported [14,31]. The concentration-time pro-
ﬁle  of TDG, and TDG plus TDGO is similar; both of them
were higher on days 3–4 after exposure and then gradually
decreased from day 5 to day 7 (Fig. 2A).
The concentration of TDG and TDG plus TDGO in urine
samples of patient 2 maintained at a relative high level of
ca.  2.3 ng/mL and 69 ng/mL on the beginning two sampling
days  (days 3 and 4), respectively, which was in accor-
dance with his relative severe clinical symptom. The TDG
level  in the other three patients exhibited a sudden rise
on  day 4 or 5, which may  result from the further hydrol-
ysis of SM that becomes sequestered in adipose tissue
because of its lipophilic nature and from the hydrolysis
of unstable SM-macromolecule covalent complex [32]. The
highest  concentration of TDG was 4.34 ng/mL in the sam-
ples  of patient 3 on day 4, who exhibited an exception
of facial injury, indicating that an inhalational exposed
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Table 2
Amount of hydrolysis/oxidation products and -lyase metabolites of sulfur mustard in samples from four individual patients.a
Patient (burn degree) Day after exposure Urined Bloode Exudatef
TDGc TDG + TDGOb,c SBMTEb,c SBMSE MSMTESE SMO SBMSE MSMTESE SMO  TDG TDGO SBMSE MSMTESE
1 (I◦ 1%) 3 0.48 29.3 78.2 12.7 44.9 D 0.06 0.17
4 1.30 14.6 50.7 64.7 26.8 NA  NA
5 1.13 5.11 0.39 7.74 4.93 0.04 0.11 NA
6  0.26 5.02 0.03 ND 0.58 0.01 0.01
7 0.30 2.30 0.14 ND 0.08 ND ND
2  (I◦ 15% II◦ 3%) 3 2.30 68.6 6.30 3.76 2.22 D 0.02 0.04 15.5 1080 343 0.06 0.04
4  2.25 69.5 4.44 14.1 8.73 NA NA 13.7 1165 428 0.05 0.04
5  0.44 5.78 0.02 ND 0.14 0.01 0.01 0.74 4430 1605 0.04 0.03
6  0.30 4.05 0.02 ND 0.08 ND ND 1.37 5900 1370 0.06 0.03
7  0.30 11.7 0.12 ND 0.08 ND ND NA NA NA NA NA
3 (I◦ 7% II◦ 2%) 3 1.65 54.1 163 183 47.0 D 0.24 0.59 0.12 33.8 4.94 0.44 0.61
4  4.34 25.9 58.0 151 51.6 NA NA 0.05 24.9 11.2 0.39 0.55
5  1.05 3.68 4.53 14.7 19.8 0.05  0.17 0.13 100 18.7 0.25 0.23
6  1.04 5.58 0.16 ND 1.55 0.01 0.04 0.40 148 25.1 0.10 0.11
7  0.30 2.20 0.06 ND 0.06 ND ND NA NA NA NA NA
4 (I◦ 8% II◦ 2%) 3 1.00 32.2 74.3 128 138 D 0.27 0.47 0.85 2.81 7.22 0.39 0.17
4  0.90 23.3 49.6 158 76.6 NA NA 0.73 20.2 7.58 0.38 0.18
5  1.62 9.44 15.9 32.5 23.8 0.06 0.17 0.16 ND 6.38 0.19 0.09
6  0.30 5.47 2.0 13.5 10.5 0.03 0.17 0.90 ND 7.08 0.18 0.12
7  0.30 4.32 1.22 2.14 1.87 0.03 0.05 NA NA NA NA NA
Abbreviations: ND, not detected; NA, not applicable; D, detected but the amount is below LLOQ which cannot be accurately measured.
a Results are showed for determinations performed in duplicate or triplicate. The unit of measurement is ng/mL.
b After reduction with TiCl3.
c detected by GC–MS methods.
d SMO, TDG, TDGO, SBSNAE and SBMTE were not detected or found in the urine samples by HPLC–MS/MS method.
e TDG, TDGO, SBSNAE and SBMTE were not detected or found in the blood samples by HPLC–MS/MS method.
f SBSNAE and SBMTE were not found in the exudate samples by HPLC–MS/MS method.
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Fig. 2. Hydrolysis/oxidation products and -lyase metabolites of sulfur mustard in urine, blood and exudate samples from four individual patients. Results
are  showed for determinations performed in duplicate or triplicate. (A) The TDG plus TDGO concentration and SBMTE concentration in urine samples
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C)  The hydrolysis/oxidation products and -lyase metabolites including 
atients  2–4 using UPLC–MS/MS method.
oute probably occurred and resulted in a more severe
nd complex symptom. Moreover, the concentration of
DG  of patient 3 was higher than patient 4, although the
hemical burn areas of the two individuals were almost
ame. The TDG level of patient 1 was the lowest among
he  exposed patients corresponding to the longest asymp-
omatic latency period and the smallest chemical burn area.
ll  TDG in urine samples kept at a relative low level of no
ore  than 5 ng/mL in case of no sampling time point within
8  h after exposure. Our previous results of TDG in sam-
les  of SM dermal exposed rabbit achieved maximum at
he  ﬁrst two days and then decreased quickly over 2 days
fter  exposure [25]. Here we can rationally suppose that
or  these patients, their TDG level in day 1 and 2 would be
igher  than the values of following days.
The maximum levels of TDG plus TDGO in urine sam-
les collected on day 3 were 54.1, 32.2 and 29.3 ng/mL for
atients  3, 4 and 1, respectively, with a positive correla-
ion with the severity of the symptoms. On days 5 to 7, the
oncentrations of TDG plus TDGO for these four patients
ere well above the lower limit of quantiﬁcation (LLOQ)
f  0.3 ng/mL, but were lower than the background values,
ndicating an elimination mechanism toward intoxicant
n  vivo has taken effect. -Glucuronidase was also used
o  release the TDG and TDGO metabolites from their glu-
uronide or sulphate conjugates and the results revealed
hat  there was little conjugated TDG or TDGO existed in
xposed  human (data not shown).
TDG and TDGO as two individual analytes were also
irectly detected in blood and exudate samples with the
alidated UPLC–MS/MS method developed in our labora-
ory  [21]. TDG and TDGO were not detected in the blood
amples of patients after 48 h of exposure. According to
ur  previous results, which showed that for SD rat dermal
xposure model, the detection time windows for quan-
iﬁcation of TDG and TDGO in plasma were 4 and 12 h,
espectively, while the detection windows of TDG and
DGO  for human patients here must be less than 48 h. On
he  contrary, a remarkably high level of TDG and TDGO
as interestingly observed in the exudate samples in the
ost-exposed days. For example, the concentration of TDGE concentration in blood samples determined by UPLC–MS/MS method.
G, TDGO, SBMSE and MSMTESE were detected in exudate samples from
of  patient 2 was 1080 ng/mL on day 3 and elevated to
5900  ng/mL on day 6, and the TDGO concentration also ele-
vated  from 343 ng/mL to 1370 ng/mL. The concentrations
of TDG and TDGO in exudate samples were in good accor-
dance with the extent of injury of the patients. After dermal
administrated, SM was directly adsorbed into skin tissue,
and  would generate large amount of hydrolyted/oxidated
products TDG and TDGO.
SMO, the direct oxidative metabolite of SM,  was also
tested in urine, blood and exudate samples from the sus-
pected  exposed patients. SMO  was  identiﬁed to be a very
minor  metabolite in rat urine and therefore it did not attract
attention as a SM biomarker before [9]. Anyway, consider-
ing  SMO  is not an endogenous substance, its existence, even
minor,  is a direct evidence for SM exposure. In our recent
work toward SM dermal exposed rats, we  found that SMO
was  a predominant component in the circulation with a
high  level in the detection time window of 12 h [21]. In this
work,  for these four patients, we found no SMO  in their
urine  samples, a low but detectable level of SMO  in plasma
samples with all values between LLOD (0.03 ng/mL) and
LLOQ  (0.05 ng/mL), and positive results in all exudate sam-
ples  of patients 2, 3 and 4. Among these three patients, a
highest  level of SMO  appeared in patient 2 with the most
serious chemical burn symptom. The concentration of SMO
on  day 6, the last sampling day, was  still kept eightfold
greater than LLOQ.
Considering the apparently positive results of TDG,
TDGO and SMO  in exudates (Fig. 2C), it is indicated that
the  determination of hydrolysis/oxidation products of SM
in  exudate is especially useful for direct evidence of SM
exposure and further rough estimation of exposure extent.
3.2.  ˇ-Lyase metabolites in urine, blood and exudate
samples
Unlike TDG and TDGO but similar as SMO, -lyase
metabolites of SM are only produced upon exposure to
SM.  In GC–MS analysis, SBMTE, SBMSE and MSMTESE
are usually reduced to one analyte, SBMTE, by treatment
with TiCl3 [15,33,34], as the method we adopted here for
gy Repor540 H. Xu et al. / Toxicolo
urine specimens. SBMTE was detected in all samples from
patients  and the concentration proﬁle showed a common
pattern for non-persistent organic toxicants (Fig. 2A). The
time-dependent proﬁle shows a decreasing curve, with a
sharp  decline from day 4 to day 5. Among all patients,
Patient 3 had the highest SBMTE level of 163 ng/mL and
58  ng/mL in urine on days 3 and 4, patients 1 and 4 had the
similar  but middle level, while patient 2, unexpectedly, had
the  lowest level of 6.30 ng/mL and 4.44 ng/mL, respectively
(Table 2). This result presumably due to large and rapid
depletion of glutathione in patient 2 with the most severe
burn  degree, maybe a quickly declined level of -lyase
metabolites was occurred beyond day 2. Another possible
reason is that different medical treatments for individuals
and varied glutathione detoxiﬁcation ability among indi-
viduals  may  also lead to the difference of such results.
Previous reports have concluded that glutathione related to
the  resistance of cells to alkylating agents and a signiﬁcant
loss of blood, hepatic and pulmonary glutathione observed
in  animals exposed to SM [35,36]. This in turn suggested
that prophylactic glutathione may  help relieve the symp-
toms  caused by SM,  which was valuable for the treatment
of  exposed individuals.
The  glutathione derived metabolites of SBSNAE, SBMTE,
SBMSE and MSMTESE were simultaneously measured by
our  UPLC–MS/MS method. While SBSNAE and SBMTE
were not detected, SBMSE and MSMTESE were positively
detected in urine, blood and exudate samples, both LLOQs
are  0.01 ng/mL for the latter two analytes. The fewest
amounts of the two -lyase metabolites were also observed
in  the body ﬂuid samples from patient 2. For three sources
of  samples, high level at tens to hundreds ng/mL of SBMSE
and  MSMTESE was observed in urine samples due to the
main  kidney metabolite pathway of glutathione conju-
gates. The concentrations of the two -lyase metabolites
in blood or exudate samples were much lower, usually
at  sub ng/mL to ng/mL level (Fig. 2B and C). Since the -
lyase  metabolites have been veriﬁed as an unequivocal
diagnostic indicator of SM exposure, our positive results
of  such the -lyase metabolites, together with hydroly-
sis/oxidation products, can clearly provide evidence of SM
exposure  to these four patients.
3.3. DNA adducts in urine and blood samples
Previous researches have demonstrated that the DNA
alkylation and following inhibition of DNA replication were
the  molecular basis of the cytotoxicity caused by SM.
Among the known SM-DNA adducts, N7-HETEG has the
prominent abundance and has been proved to be a use-
ful  biomarker in vivo [37–39]. The methods including radio
labeling,  immunoassay and chromatography coupled with
different  detection techniques have been reported. For
example, one immunoassay based on the monoclonal anti-
body  against N7-HETEG was applied to blood samples from
two  Iranian victims of the Iran–Iraq conﬂict to conﬁrm the
exposure to SM [17]. However, there is no report of simulta-
neous  detection and quantiﬁcation of the four DNA adducts
in  blood, derma or urine specimen except UPLC–MS/MS
methods recently developed in our laboratory [26,27], thets 1 (2014) 533–543
LLOQs  of 0.005–0.010 ng/mL were achieved for these four
SM-DNA  adducts.
In  urine samples, the kind of DNA adduct is free DNA
adducts. They are directly removed from DNA strands
during the process of DNA repair, delivered into the cir-
culatory system and then passed out of the body through
the  urine. To some extent, the content of free SM-DNA
adducts in urine can directly represent the inherent easy-
to-be-repaired part of DNAs, and can be used to evaluate
the  damage of DNAs. The four free alkylated bases as the
form  of SM-DNAs adducts were positively detected from
the  ﬁrst sampling day (day 3) up to day 32 after expo-
sure, with a maximum peak on days 4–7 (Fig. 3). Of  all
four  SM-DNA adducts, N7-HETEG was  the most abundant
one, Bis-G and N3-HETEA was  less, O6-HETEG was  the
least. This is in accordance with the results observed in
rabbits  that approximately 67%, 23% and 10% of the DNA
alkylation products were N7-HETEG, Bis-G and N3-HETEA
respectively, while just ca. 0.1% of the total alkylation
was  O6-HETEG [27]. In spite of the minimum content,
O6-HETEG has been noted for its interference of G-C
Watson-Crick base pairs, also accepted as a most impor-
tant  biomarker of DNA damage by SM [40]. The results here
initially  revealed that all the four SM-DNA adducts could
be  used to determine the human exposure to SM, and the
concentrations of DNA adducts are positively related to the
exposure  extent. Patients 2, 3 and 4 always have a higher
level  of the DNA adducts than patient 1, whose injury was
the  lightest. The time-dependent proﬁles of the patients are
similar,  especially for patient 3 and 4 due to their almost
equal burn area and degree. Taking patient 3 as an example,
N7-HETEG achieved the maximum of 3.55 ng/mL on day 4,
decreased  to 0.2 ng/mL on day 13 and then kept at the sub
ng/mL  level until day 32. Other three SM-DNAs have same
trends.
In  blood samples, the adducts are covalently alkylated
to DNAs, which need further heat or enzymatic cleavage
procedures when processing the samples. In our experi-
ment, the four SM-DNA adducts were detected after DNA
extraction and digestion, and showed positive results for
all  patients on day 3 after exposure with concentrations
of 0.03–0.09 ng/mL, and then decreased to a detectable
level until day 14 (data not shown). N7-HETEG was still
the  most abundant one in the blood sample, Bis-G and
N3-HETEA were the less, and few O6-HETEG was detected.
The detected low concentrations of the SM-DNA adducts in
plasma  should be due to the sampling time point outside
the  detection window of 24 h for blood samples suffered to
DNA  adducts in vivo detection. Despite of the low level, the
concentrations of the four SM-DNA adducts also demon-
strated a good relationship with the exposure extent of the
patients.
3.4.  HETE-Val adducts in blood samples
N-alkylated valine originated from the N-terminal
valine of hemoglobin as a biological marker of expo-
sure to alkylating agents has been previously reported
[16,17,41]. Recent studies also showed that HETE-Val pro-
duced  in the hemoglobin of blood treated with SM in vitro
or  in vivo. Blood samples of the four patients collected
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Fig. 3. Time-dependent proﬁles of four sulfur mustard-DNA adducts in urine samples from exposed individuals. An isotope-dilution ultrahigh performance
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re  showed for determinations performed once due to the limited samplerom days 3 to 95 after exposure were analyzed to proﬁle
ETE-Val (Fig. 4). High concentrations of HETE-Val were
ound  on days 3–7 in patients, and continuously declined
ince the second week after exposure. The time-dependent
ig. 4. Persistence of N-terminal valine adduct in the blood of four
atients after exposure to sulfur mustard. The blood samples were
reated by solid phase extraction followed by modiﬁed Edman degrada-
ion and the extracted HETE-Val adducts were determined by established
CI–GC/MS method. Results are showed for determinations performed
nce due to the limited sample volume.ith solid phase extraction was  performed to simultaneously detect the
ne samples. (a) Patient 1; (b) patient 2; (c) patient 3; (d) patient 4. Results
e.
relationships of patients 2, 3 and 4 were similar, except
for  slightly higher concentrations of patient 3. With regard
to  patient 3, the concentration of HETE-Val level was ca.
120  pmol/g hemoglobin in the ﬁrst week, and decreased
to 90 pmol/g hemoglobin one month later, further grad-
ually  decreased to 10 pmol/g hemoglobin three months
after exposure (day 95), which was  still above the LLOD
(7  pmol/g). With regard to patient 1 of much lower HETE-
Val  concentration in his whole treated course, which is
corresponding to a minimal chemical burn, the HETE-Val
level was  20 pmol/g hemoglobin on day 3 and decreased to
9.8  pmol/g hemoglobin one month later, and to 2.3 pmol/g
hemoglobin two months after exposure (day 60). Our
results revealed a long persistence of SM-hemoglobin
adduct in human plasma, which is in good accordance with
the  life-time of the erythrocyte of the human (approximate
120 days). It is indicated that HETE-Val adduct provides
a  valuable biomarker of SM exposure, especially for the
retrospective analysis of the archived samples.
4. ConclusionsThe accidental human exposure to chemical that caused
blisters has provided a precious opportunity to comprehen-
sively investigate the four types of SM biomarkers in urine,
blood  and exudate samples collected from four patients
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Fig. 5. Time course of the biomarkers for the retrospective analysis of
sulfur mustard exposure to human. The detection windows of the metabo-
lites or adducts for clinical samples collected from sulfur mustard-exposed
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167–173.
[15]  J.R. Barr, C.L. Pierce, J.R. Smith, B.R. Capacio, A.R. Woolﬁtt, M.I. Solano,human were established on the basis of the detection results.
with different extent of exposure. LC–MS and GC–MS meth-
ods  with high sensitivity and selectivity developed in our
laboratory were used. Hydrolysis/oxidation products, glu-
tathione  derived -lyase metabolites, DNA adducts and
hemoglobin adducts were successfully detected in the
samples, mutually verifying the SM exposure to the four
individuals. The concentrations of the biomarkers in spec-
imens  revealed a good correlation with the severity of the
patient’s  symptom.
Most  importantly, the data presented here also yield
insights into the preliminary establishment of detec-
tion window of four kinds of metabolites or adducts for
human,  as shown in Fig. 5, which includes “double what”
and  “when”, i.e., to determine which kind of SM related
biomarkers (“what”) in which time(“when”), and in which
sample(“what”).
During  the ﬁrst week after a SM exposure, both urine
and blister exudate samples are valuable biomedical sam-
ples,  and the hydrolysis/oxidation products, TDG and
TDGO,  combining with the -lyase metabolites, SBMTE,
SBMSE and MSMTESE can be detected in the urine and
exudate samples during the early period, as ﬁrstly noted
here,  direct oxidation product, SMO, can be also detected
in  exudate samples for early diagnosis of SM exposure.
As for blood samples, a low level of SMO, SBMSE and
MSMTESE were observed, and TDG, TDGO and SBMTE were
not  detected here due to the detection windows for them
in  plasma are always within 12 h.
From the ﬁrst week to the end of one month, covalent
binding adducts including four DNA adducts can be found
excreted in urine from the ﬁrst sampling day up to day
30.  Although SM-DNA adducts are assumed to circulate in
blood  for a long period up to several months according to
the  long lifetime of DNAs, it is not suggested to continually
determine such biomarkers in blood samples in one month,
since  they only show relative high concentration in the ﬁrst
3  days after exposure. From the ﬁrst week to the end of one
quarter,  the SM-hemoglobin adduct, here refers to HETE-
Val,  is likely to be a satisﬁed choice in blood samples to
conﬁrm SM exposure. Even over 90 days after exposure,
HETE-Val is still persistent in the specimens, showing greatts 1 (2014) 533–543
importance to the retrospective researches and the clinical
treatment monitoring of SM exposed humans.
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